EGFR (Epidermal Growth Factor Receptor)
EGFR
Receptor tyrosine kinase driving cell proliferation, commonly mutated in NSCLC.
Fonction
Activating mutations drive oncogenic signaling. Targeted by TKIs (erlotinib, osimertinib) and antibodies (cetuximab).
Médicaments agissant sur cette cible
| Médicament | Action | Principal |
|---|---|---|
| Trastuzumab | Antagonist | Oui |